Platelet aggregation and coagulation factors in orthopedic surgery

Journal of Thrombosis and Thrombolysis

Volumn 38, Issue 4, 2014, Pages 430-438

  Oberweis, Brandon S ^a   Cuff, Germaine ^a   Rosenberg, Andrew ^a   Pardo, Luis ^a   Nardi, Michael A ^a   Guo, Yu ^b   Dweck, Ezra ^a   Marshall, Mitchell ^a   Steiger, David ^a   Stuchin, Steven ^b   Berger, Jeffrey S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arterial thrombosis; Coagulation factors; Major bleeding; Perioperative management; Platelet aggregation

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING PARAMETERS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HIP SURGERY; HUMAN; HYPERCOAGULABILITY; IMPEDANCE; INTRAOPERATIVE PERIOD; KNEE SURGERY; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; SPINE SURGERY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; AGED; BLOOD CLOTTING; METABOLISM; MIDDLE AGED; PATIENT MONITORING; PHYSIOLOGY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROCEDURES; THROMBOCYTE ACTIVATION; TRENDS;

AGED; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; ORTHOPEDIC PROCEDURES; PLATELET ACTIVATION; PLATELET AGGREGATION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 84910127552     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1078-1     Document Type: Article

References (36)

1. Oberweis BS, Nukala S, Rosenberg A, Guo Y, Stuchin S, Radford MJ, Berger JS (2013) Thrombotic and bleeding complications after orthopedic surgery. Am Heart J 165(3):427–433. doi:10.1016/j.ahj.2012.11.005
2. Chong CP, Lam QT, Ryan JE, Sinnappu RN, Lim WK (2009) Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients. Age Ageing 38(2):168–174. doi:10.1093/ageing/afn231
3. Ausset S, Auroy Y, Lambert E, Vest P, Plotton C, Rigal S, Lenoir B, Benhamou D (2008) Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome. Eur J Anaesthesiol 25(2):158–164. doi:10.1017/S0265021507001202
4. Jules-Elysee K, Urban MK, Urquhart B, Milman S (2001) Troponin I as a diagnostic marker of a perioperative myocardial infarction in the orthopedic population. J Clin Anesth 13(8):556–560
5. Lison S, Weiss G, Spannagl M, Heindl B (2011) Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis 22(3):190–196. doi:10.1097/MBC.0b013e328343f7be
6. Cushman M (2007) Epidemiology and risk factors for venous thrombosis. Semin Hematol 44(2):62–69. doi:10.1053/j.seminhematol.2007.02.004
7. Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451(7181):914–918. doi:10.1038/nature06797
8. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C (2005) Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353(22):2373–2383. doi:10.1056/NEJMra052717
9. Hermanides R, Ottervanger J, Elvan A, Ramdat Misier A (2009) Life-threatening perforation of a defibrillation lead. Neth Heart J 17(3):113–114
10. Mangano DT (1990) Perioperative cardiac morbidity. Anesthesiology 72(1):153–184
11. Mangano DT (1998) Adverse outcomes after surgery in the year 2001—a continuing odyssey. Anesthesiology 88(3):561–564
12. Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, Krupski WC (1991) Perioperative myocardial ischemia in patients undergoing noncardiac surgery—I: incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol 17(4):843–850
13. Landesberg G, Mosseri M, Zahger D, Wolf Y, Perouansky M, Anner H, Drenger B, Hasin Y, Berlatzky Y, Weissman C (2001) Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 37(7):1839–1845
14. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW (1998) Myocardial infarction after noncardiac surgery. Anesthesiology 88(3):572–578
15. Samama CM, Thiry D, Elalamy I, Diaby M, Guillosson JJ, Kieffer E, Coriat P (2001) Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 94(1):74–78
16. Gibbs NM, Crawford GP, Michalopoulos N (1992) Postoperative changes in coagulant and anticoagulant factors following abdominal aortic surgery. J Cardiothorac Vasc Anesth 6(6):680–685
17. Kobayashi S, Yokoyama Y, Matsushita T, Kainuma M, Ebata T, Igami T, Sugawara G, Takahashi Y, Nagino M (2012) Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy. Arch Surg 147(10):909–917. doi:10.1001/archsurg.2012.998
18. Bezeaud A, Denninger MH, Dondero F, Saada V, Venisse L, Huisse MG, Belghiti J, Guillin MC (2007) Hypercoagulability after partial liver resection. Thromb Haemost 98(6):1252–1256
19. Toth O, Calatzis A, Penz S, Losonczy H, Siess W (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96(6):781–788
20. Ausset S, Auroy Y, Verret C, Benhamou D, Vest P, Cirodde A, Lenoir B (2010) Quality of postoperative care after major orthopedic surgery is correlated with both long-term cardiovascular outcome and troponin IC elevation. Anesthesiology 113(3):529–540. doi:10.1097/ALN.0b013e3181eaacc4
21. Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR (2012) Total knee arthroplasty volume, utilization, and outcomes among medicare beneficiaries, 1991–2010. JAMA 308(12):1227–1236. doi:10.1001/2012.jama.11153
22. Esmon CT (2004) The impact of the inflammatory response on coagulation. Thromb Res 114(5–6):321–327. doi:10.1016/j.thromres.2004.06.028
23. D’Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM (1985) Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest 15(6):308–312
24. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P (2007) Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105(4):905–917. doi:10.1213/01.ane.0000280481.18570.27
25. Kageyama K, Nakajima Y, Shibasaki M, Hashimoto S, Mizobe T (2007) Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty. J Thromb Haemost 5(4):738–745. doi:10.1111/j.1538-7836.2007.02443.x
26. Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC (2007) Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 106(6):1120–1127. doi:10.1097/01.anes.0000265422.07864.37
27. Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95(4):858–865
28. Jungheinrich C, Sauermann W, Bepperling F, Vogt NH (2004) Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6 %) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D 5(1):1–9
29. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P (2001) Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 92(4):855–862
30. Hermanides J, Huijgen R, Henny CP, Mohammad NH, Hoekstra JB, Levi MM, DeVries JH (2009) Hip surgery sequentially induces stress hyperglycaemia and activates coagulation. Neth J Med 67(6):226–229
31. Nygaard OP, Unneberg K, Reikeras O, Osterud B (1990) Thromboplastin activity of blood monocytes after total hip replacement. Scand J Clin Lab Invest 50(2):183–186. doi:10.1080/00365519009089151
32. Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kromann O, Pedersen J, Sorensen KE (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85(1):61–65
33. Berger JS, Becker RC, Kuhn C, Helms MJ, Ortel TL, Williams R (2013) Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb Haemost 109(1):85–92. doi:10.1160/TH12-03-0202
34. Trip MD, Cats VM, van Capelle FJ, Vreeken J (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322(22):1549–1554. doi:10.1056/NEJM199005313222201
35. Pittens CA, Bouman HJ, van Werkum JW, ten Berg JM, Hackeng CM (2009) Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests. J Thromb Haemost 7(11):1929–1932. doi:10.1111/j.1538-7836.2009.03585.x
36. Wallen NH, Ladjevardi M, Albert J, Broijersen A (1997) Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Thromb Res 87(1):151–157